Letter to the Editor
Risk of future haemolytic disease of the fetus and newborn following the transfusion of Rh(D)-positive blood products to Rh(D)-negative children
Mark H. Yazer,
Corresponding Author
Mark H. Yazer
Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA
Vitalant, Pittsburgh, Pennsylvania, USA
Correspondence
Mark H. Yazer, Department of Pathology, University of Pittsburgh School of Medicine, 3636 Blvd of the Allies, Pittsburgh, PA 15213, USA.
Email: [email protected]
Search for more papers by this author Philip C. Spinella,
Philip C. Spinella
Department of Pediatrics, Division of Critical Care Medicine, Washington University in St Louis, St Louis, Missouri, USA
Search for more papers by this author Jansen N. Seheult,
Jansen N. Seheult
Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA
Vitalant, Pittsburgh, Pennsylvania, USA
Search for more papers by this author
Mark H. Yazer,
Corresponding Author
Mark H. Yazer
Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA
Vitalant, Pittsburgh, Pennsylvania, USA
Correspondence
Mark H. Yazer, Department of Pathology, University of Pittsburgh School of Medicine, 3636 Blvd of the Allies, Pittsburgh, PA 15213, USA.
Email: [email protected]
Search for more papers by this author Philip C. Spinella,
Philip C. Spinella
Department of Pediatrics, Division of Critical Care Medicine, Washington University in St Louis, St Louis, Missouri, USA
Search for more papers by this author Jansen N. Seheult,
Jansen N. Seheult
Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA
Vitalant, Pittsburgh, Pennsylvania, USA
Search for more papers by this author
First published: 23 June 2021
No abstract is available for this article.
REFERENCES
- 1Seheult JN, Stram M, Pearce T, Bub CB, Emery SP, Kutner J, et al. The risk to future pregnancies of transfusing Rh(D)-negative females of childbearing potential with Rh(D)-positive red blood cells during trauma resuscitation is dependent on their age at transfusion. Vox Sang. 2021. doi: 10.1111/vox.13065.
- 2Tamai Y, Ohto H, Takahashi H, Kitazawa J, Pediatric RBC Alloimmunization Consortium. Transfusion-related alloimmunization to red blood cell antigens in Japanese pediatric recipients. Transfus Med Rev. 2021; 35: 29–36.
- 3Evers D, Middelburg RA, de Haas M, Zalpuri S, de Vooght KMK, van de Kerkhof D, et al. Red-blood-cell alloimmunisation in relation to antigens' exposure and their immunogenicity: a cohort study. Lancet Haematol. 2016; 3:e284-92.
- 4Yazer MH, Triulzi DJ, Sperry JL, Corcos A, Seheult J. Rate of RhD-alloimmunization after the transfusion of RhD-positive red blood cell containing products among injured patients of childbearing age: single center experience and narrative literature review. Hematology. 2021; 26: 321–7.
- 5Raval J, Madden K, Neal MD, Moore, S. Anti-D alloimmunization in Rh(D) negative adults with severe traumatic injury. Transfusion. in press.
- 6Leonard JC, Josephson CD, Luther JF, Wisniewski SR, Allen C, Chiusolo F, et al. Life-threatening bleeding in children: a prospective observational study. Crit Care Med. 2021. doi: 10.1097/CCM.0000000000005075.
